Clinical Observation of the Union Treatment of Hepatic Transcatheter Arterial Chemoembolization and Percutaneous Microwave Coagulation Therapy for Hepatic Cellular Carcinoma

QIU Shao-min,CHEN Gang,LI Hong-bo

DOI: https://doi.org/10.3969/j.issn.1671-7562.2011.05.006

2011-01-01

Abstract:Objective: To contrast the curative effect of the union treatment of transcatheter arterial chemoembolization(TACE) and percutaneous microwave coagulation therapy(PMCT) with the simple treatment of TACE in the treatment of hepatic cellular carcinoma(HCC).Methods: Sixty patients with HCC were randomly divided into two groups.Treatment group included 34 patients,who were treated with TACE+ PMCT,while control group included 26 patients,who were treated with TACE alone.Sixty patients were followed up 6-36 months to analyze the difference of therapeutic efficacy,survival rate and adverse reaction between two groups.Results: In treatment group(34 patients) PR has 9 cases,SD has 16 cases,PD has 9 cases,while in control group(26 patients) PR has 4 cases,SD has 13 cases,PD has 9 cases.The treatment group survival over 12 months accounted for 24/34(70.59%),while control group only six were able to survive more than 12 months,accounting for 6/26(23.08%).It has statistical difference for comparing one year survival rate between treatment group and control group(P0.01).It has no statistical difference for comparing adverse reaction among the two groups.Conclusion: PMCT combined with TACE can enhance the curative effect on HCC and help increase the patients' survival rate,which is a valuable remedy for HCC to prolong long-term survival rate.